Cointime

Q Therapeutics

company

About

Q Therapeutics develops cell-based therapeutics which focuses on developing novel products to treat amyotrophic lateral sclerosis, etc.,

  • 1 - 10

Highlights

Total Funding Amount
$15M
Funding Rounds
1
Investors
2

Details

Last Funding Type
Series Unknown
Last Funding Money Raised
$15M
Industries
Biotechnology,Health Care,Therapeutics
Founded date
Jan 1, 2004
Number Of Employee
1 - 10
Operating Status
Active

Q Therapeutics is a development stage company, engages in the development of human cell-based therapies for the treatment of degenerative diseases of the brain and spinal cord. The company develops Q-Cells that is intended for the treatment of amyotrophic lateral sclerosis, multiple sclerosis, transverse myelitis, traumatic spinal cord injury, and Parkinson’s disease, as well as for Alzheimer’s disease, traumatic brain injury, cerebral palsy, Leukodystrophies and central nervous system storage diseases, and peripheral neuropathies. Q Therapeutics is headquartered in Salt Lake City, Utah.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
$15M
Q Therapeutics has raised a total of $15M in funding over 2 rounds. Their latest funding was raised on Feb 15, 2008 from a Series Unknown round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Feb 15, 2008 Series Unknown $15M 2 — — Detail

Investors

Number of Lead Investors
Number of Investors
—
2
Q Therapeutics is funded by 2 investors. University of Utah Endowment and Salt Lake Life Science Angels are the most recent investors.
Investor Name Lead Investor Funding Round
University of Utah Endowment — Series Unknown
Salt Lake Life Science Angels — Series Unknown
Cointime
เนื้อหา
บริษัท